Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? (Deficit) Equity (Details)

v3.22.2.2
Stockholders’ (Deficit) Equity (Details) - USD ($)
1 Months Ended 9 Months Ended
Jul. 31, 2021
Sep. 30, 2022
Dec. 31, 2021
Jul. 01, 2017
Stockholders’ (Deficit) Equity (Details) [Line Items]        
Common stock, shares authorized   200,000,000 200,000,000  
Common stock par value (in Dollars per share)   $ 0.001 $ 0.001  
Shares issued       62,181
Exchange for cash price, per unit (in Dollars per share) $ 5     $ 0.013
Exercise price (in Dollars per share) $ 6 $ 6    
Warrants term 5 years 5 years    
Converted shares   736,773    
Convertible debt shares granted   184,193    
Common stock voting rights   Each holder of shares of common stock shall be entitled to one vote for each share thereof held.     
Preferred stock, shares authorized   10,000,000 10,000,000  
Preferred stock, par value (in Dollars per share)   $ 0.001 $ 0.001  
Preferred stock, issued    
Preferred stock, outstanding    
Common Stock [Member]        
Stockholders’ (Deficit) Equity (Details) [Line Items]        
Shares issued 5,000,000      
Common stock price, per share (in Dollars per share) $ 4.99      
Warrants [Member]        
Stockholders’ (Deficit) Equity (Details) [Line Items]        
Shares issued 4,000,000      
Exercise price (in Dollars per share) $ 125      
Purchase of additional warrants shares 600,000      
Proceeds of warrants (in Dollars) $ 7,500